News in Numbers
82%
Venture financing for mRNA-based innovator vaccines declined by 82% from $510m in 2023 to $90m in the 2025’s year to date (YTD), according to GlobalData analysis.
$445m
AstraZeneca has unveiled its new $445m Texas manufacturing facility expansion as the drugmaker aims to meet increasing demand for hyperkalaemia treatment Lokelma.
84%
Merck’s healthcare division in Canada and the US, EMD Serono, has signed an agreement with the Trump administration to expand access to its IVF therapies, with patients to benefit from an 84% reduction on list prices for the IVF protocol.
2
In October, the European Medicines Agency’s committee, the CHMP, recommended the approval of the first treatment for non-cystic fibrosis bronchiectasis and one medicine to treat persistent or chronic immune thrombocytopenia.
1 in 5
One in 5 people experience a mental health condition during crises such as natural disasters, conflicts and disease outbreaks, according to the World Health Organization (WHO).
